[Drug name] Panax notoginseng saponins/ Panax notoginseng saponins
[Approval number] ZTCB20160060 Dian002
[Properties] This product is light yellow amorphous powder, bitter, slightly sweet, and hygroscopic
[Source] Araliaceae plant notoginseng
[Main ingredients]
Ginsenoside Rb1, Ginsenoside Rg1, Notoginsenoside R1. It is based on extraction and separation technology to extract effective medicinal ingredients from high-quality Panax notoginseng, including more than 20 kinds of saponin active substances, 17 kinds of trace elements, protein, rich vitamins, polysaccharides, etc.
[Introduction]
This product is a medicine for promoting blood circulation, removing blood stasis, and activating collaterals. It has the effect of inhibiting platelet aggregation and increasing cardiovascular flow. It is used for cerebrovascular sequelae, central retinal vein occlusion, ocular anterior chamber hemorrhage, etc.
[Specifications] 20Kg/bag/cardboard drum; 25Kg/bag/cardboard drum
[Storage conditions] Sealed and placed in a cool and dry place
[Manufacturer] Yunnan Runjia Pharmaceutical Co., Ltd.
[Detailed address]
Dongyao Area, Guichao Biological Resources Processing Park, Guichao Town, Funing County, Wenshan Prefecture, Yunnan Province
This product is a semi-finished raw material and is only sold to manufacturers with relevant qualifications or related distribution companies. It is not sold to individuals, and it is not recommended to eat directly. The potential effects and applications involved in the product introduction are all from publicly published literature;
Bulk goods 20Kg/bag/barrel; the quotation includes tax and freight, the product can provide samples, and the product will be shipped after the test is passed; the corresponding test report is attached to each batch of the same batch, and the product quality is strictly implemented in accordance with the test standard; the colors of different batches There is a slight deviation, which is normal